0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-10-01 Sage Accounts Production Advanced 2024 - FRS102_2024 60 60 60 xbrli:pure xbrli:shares iso4217:GBP 15126460 2023-10-01 2024-09-30 15126460 2024-09-30 15126460 2023-09-30 15126460 bus:Director1 2023-10-01 2024-09-30 15126460 core:WithinOneYear 2024-09-30 15126460 core:ShareCapital 2024-09-30 15126460 core:RetainedEarningsAccumulatedLosses 2024-09-30 15126460 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-09-30 15126460 core:CostValuation core:Non-currentFinancialInstruments 2024-09-30 15126460 core:Non-currentFinancialInstruments 2024-09-30 15126460 bus:Director1 2024-09-30 15126460 bus:SmallEntities 2023-10-01 2024-09-30 15126460 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 15126460 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 15126460 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 15126460 bus:FullAccounts 2023-10-01 2024-09-30
COMPANY REGISTRATION NUMBER: 15126460
Edwards Holdings (Medical) Limited
Filleted Unaudited Financial Statements
30 September 2024
Edwards Holdings (Medical) Limited
Statement of Financial Position
30 September 2024
2024
Note
£
£
Fixed assets
Investments
4
60
Current assets
Debtors
5
94,005
Cash at bank and in hand
3,859
--------
97,864
Creditors: amounts falling due within one year
6
70,291
--------
Net current assets
27,573
--------
Total assets less current liabilities
27,633
--------
Net assets
27,633
--------
Capital and reserves
Called up share capital
60
Profit and loss account
27,573
--------
Shareholders funds
27,633
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the period ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Edwards Holdings (Medical) Limited
Statement of Financial Position (continued)
30 September 2024
These financial statements were approved by the board of directors and authorised for issue on 28 May 2025 , and are signed on behalf of the board by:
Ms D Edwards
Director
Company registration number: 15126460
Edwards Holdings (Medical) Limited
Notes to the Financial Statements
Period ended 30 September 2024
1. General information
The company is a private company limited by shares, registered in England. The address of the registered office is Lyndhurst, 1 Cranmer Street, Long Eaton, Nottingham, NG10 1NJ.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.
Creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost.
4. Investments
Shares in group undertakings
£
Cost
At 1 October 2023
Additions
60
----
At 30 September 2024
60
----
Impairment
At 1 October 2023 and 30 September 2024
----
Carrying amount
At 30 September 2024
60
----
5. Debtors
2024
£
Other debtors
94,005
--------
6. Creditors: amounts falling due within one year
2024
£
Amounts owed to group undertakings and undertakings in which the company has a participating interest
69,091
Other creditors
1,200
--------
70,291
--------
7. Director's advances, credits and guarantees
During the period the director entered into the following advances and credits with the company:
2024
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Ms D Edwards
173,971
( 80,000)
93,971
----
---------
--------
--------